ZKZohaib Khan

Zohaib Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zohaib Khan has a total of 204 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Embedding cognitive behavioural therapy for depression among patients with tuberculosis in Khyber Pakhtunkhwa, Pakistan: insights from a pilot trial process evaluation

    by Fayaz Ahmad, Aiman Niaz, Fatima Khalid Qazi, Shaista Rasool, Rubab Jawed, Asad Ullah, Nishani Fonseka, Saima Shiekh, Zohaib Khan, Saeed Farooq

    Objectives To assess the acceptability and feasibility of a cognitive behavioural therapy (CBT) intervention for depression in tuberculosis (TB) care in Pakistan and to identify contextual factors influencing its implementation. We also evaluated training for TB health workers (TBHWs) and refined the intervention and trial procedures. Design A mixed-methods process evaluation was conducted concurrently with the in-built pilot trial. Setting The COgNitive Therapy for depRessiOn in TubercuLosis (CONTROL) intervention, comprising CBT therapy, was delivered at four TB Basic Management Units that provide drug-sensitive TB services and are located within primary, secondary and tertiary healthcare facilities in two districts of Khyber Pakhtunkhwa Province, Pakistan: Peshawar and Haripur. The semi-structured interviews (SSIs) and fidelity assessments were conducted on-site, while training and focus group discussions (FGDs) were held at Khyber Medical University, Peshawar, Pakistan. Participants Quantitative data examined recruitment, retention, follow-up completion, therapist competency and training feedback. Qualitative data from SSIs (n=15) and FGDs (n=3) with patients, professionals who delivered CBT, medical officers (MOs) and trial staff were analysed thematically using a framework approach. Primary and secondary outcome measures Acceptability, feasibility, contextual influencing factors of intervention and trial procedures, including intervention refinement and TBHW training effectiveness. Results Qualitative and quantitative findings converged across the Medical Research Council (MRC) framework. 1). Implementation showed that recruitment, retention, intervention fidelity and therapist competency were high, and training was positively received. Qualitative findings supported feasibility while identifying workload, assessment burden, space availability and patient literacy as implementation challenges requiring adaptation. 2). Mechanisms of impact showed strong therapist competency in interpersonal effectiveness, collaboration, guided discovery and feedback converged with reports of therapeutic alliance and open communication. Competent delivery of CBT techniques was accompanied by perceived improvements in emotional well-being, motivation, treatment adherence and interpersonal relationships. 3). Context: language, literacy, age and access to digital resources influenced patient understanding and engagement. Patient-centred communication and visual materials improved comprehension, while limited mobile-phone access, workload, scheduling and intervention resources challenged delivery and continuity of care. Conclusions The findings support the feasibility and acceptability of integrating CBT into routine TB care. Insights from this evaluation guided the refinement of the CBT intervention and implementation strategy for the definitive CONTROL trial. Future work should assess the intervention’s effectiveness, scalability and cost-effectiveness.

  • Open Access

    Compliance with post-extraction instructions and its association with alveolar osteitis (dry socket): a prospective observational study

    by Aniqa Saleem, Nadia Khaleeq, Tanzeel Salim Gandapur, Nazneen Khanum, Zohaib Khan, Khalid Rehman, Zeeshan Kibria

  • Open Access

    Implementation Determinants of Integrated Tuberculosis and Diabetes Care in South Asian Association for Regional Cooperation (SAARC) Countries: A Systematic Review

    by Saima Aleem, Saima Afaq, Suneel Gill, Bilal Ahmad, Zunaira Michael, Rida Zarkaish, Zohaib Khan

    Background: Tuberculosis (TB) and diabetes mellitus (DM) represent a growing syndemic in low- and middle-income countries (LMICs), particularly across South Asia. The bidirectional relationship between these diseases exacerbates health outcomes and increases system burdens. Although the World Health Organization has advocated for integrated management of TB and DM, implementation remains inconsistent across the SAARC region. This systematic review aims to identify and analyse implementation determinants of integrated TB and DM care in SAARC countries. Methods: We conducted a systematic review following PRISMA 2020 guidelines. searching MEDLINE (via Ovid), EMBASE, Web of Science, Cochrane CENTRAL, and CINAHL for peer-reviewed studies. Grey literature was sourced from Google Scholar and citation search. Four reviewers independently screened title, abstract and full text using Rayyan. Using a structured Excel form, two reviewers extracted data. Quality assessment was conducted by using Mixed Methods Appraisal Tool (MMAT). A narrative synthesis was conducted in line with SWiM guidelines to categorize implementation determinants as barriers or facilitators. Results: Ten studies met the inclusion criteria and were conducted across five SAARC countries: India (n = 7), Pakistan (n = 1), Bangladesh (n = 1), and Sri Lanka (n = 1). Identified facilitators included political commitment, use of digital tools, and training of healthcare workers. Barriers encompassed inadequate infrastructure and finances, workforce shortages, lack of standardized guidelines and fragmented vertical health systems. Conclusion: Integrated TB-DM care in the SAARC region remains at an early developmental stage, with most efforts limited to pilot projects or small-scale screenings. Despite political and institutional recognition of the dual burden, scale-up is constrained by systemic barriers, resource gaps, and lack of evidence-informed implementation strategies. Future efforts should prioritize system-wide integration guided by implementation frameworks, standardized protocols, and investment in workforce and infrastructure to achieve sustainable impact. Systematic review registration PROSPERO registration number: CRD42025644263.


  • Open Access

    Non-pharmacological interventions for tobacco cessation delivered in dental settings in South Asia: a scoping review

    by Sofia Kabir, Bilal Ahmad, Maham Zahid, Saima Aleem, Shaista Nooreen, Zainab Waheed, Shaista Rasool, Muhammad Irfan, Zohaib Khan

  • Open Access

    From silos to synergy: assessing tuberculosis basic management units readiness for integrated diabetes mellitus care across different districts of Pakistan

    by Saima Aleem, Saima Afaq, Bilal Ahmad, Haroon Latif Khan, Zohaib Khan

    Background: The dual burden of tuberculosis (TB) and diabetes mellitus (DM) presents a growing challenge for health systems in low- and middle-income countries (LMICs), including Pakistan. Despite global and national policies advocating for integrated care, evidence on health facility readiness to operationalize integration remains scarce. This study assessed the readiness of TB basic management units (BMUs) to deliver integrated TB-DM care and explored implementation barriers using the Consolidated Framework for Implementation Research (CFIR). Methods: We conducted an explanatory sequential mixed-methods study from September 2024 to February 2025 across 13 TB BMUs in five districts of Pakistan. Quantitative readiness data were collected using a structured tool adapted from the WHO Service Availability and Readiness Assessment (SARA), generating a composite score across four domains. Subsequently, qualitative data were gathered through multi-stakeholder focus group discussions with healthcare providers, facility managers, patients, caregivers, and policymakers. Reflexive thematic analysis was conducted and mapped to CFIR Inner Setting constructs to contextualize quantitative findings. Results: Only one facility demonstrated high readiness, while 12 showed low readiness. Facilities lacked routine comorbidity screening, trained staff, diagnostic capacity, and essential medicines. Key barriers included inadequate infrastructure, workforce shortages, fragmented information systems, and low prioritisation of integrated care. Financial constraints and limited coordination further hindered implementation. Conclusion: This study highlights critically low readiness among TB facilities in different districts of Pakistan to deliver integrated TB-DM care, reflecting systemic weaknesses across core domains. Strengthening systems, building capacity, and improving integration strategies are essential to bridge gaps between policy and practice.


  • Open Access

    Tuberculosis and depression: cultural dynamics of comorbidity among Pashtun communities in Pakistan and Afghan refugees

    by Fayaz Ahmad, Fatima Khalid, Zohaib Khan, Maryiam Rahim, Noor Sanauddinc, Sikandar Sultan, Shaista Rasool, Mirrat Butt, Farooq Naeem, Firaz Khan, et al.

    Objectives Tuberculosis (TB) remains a significant global health challenge, ranking among the top ten causes of death worldwide. Pakistan is the fifth-highest burden country for TB globally. Patients with TB often develop depression, where cultural factors play a profound role. This study explores the cultural perceptions and beliefs that influence TB-depression comorbidity among the Pashtun ethnic population of Pakistan and Afghan refugees, with a broader aim of developing a culturally appropriate intervention for the treatment of depression in TB. Study design We conducted a qualitative study across TB treatment centres in the Haripur and Peshawar districts of Khyber Pakhtunkhwa, Pakistan. Methods The study comprised 29 in-depth interviews and 11 focus group discussions, involving 101 participants across three groups: healthcare providers, TB patients, and carers. We analyzed the data using a deductive-inductive thematic analysis approach and employed the Southampton framework for cultural adaptation of interventions. Results We identified four central themes. The first theme described the cultural norms of the region, which influence physical and psychological conditions related to TB and depression. The second theme highlighted the role of the belief system in relation to the TB-depression comorbidity. The third theme explained the existing stigma associated with TB and depression. The last theme informed the development of a culturally appropriate psychotherapy-based intervention. Conclusion Gender disparities, social stigma, family dynamics, lack of social support, and belief systems are culturally driven issues linked to TB-depression comorbidity. Psychosocial interventions must consider and integrate the socio-cultural context of the target population.

  • Open Access

    Cognitive therapy for depression in tuberculosis treatment: protocol for process evaluation of a multicenter hybrid type 1 effectiveness implementation trial in Pakistan

    by Fayaz Ahmad, Maryiam Rahim, Fatima Khalid Qazi, Zohaib Khan, Shaista Rasool, Zeeshan Kibria, Noor Sanauddin, Mirrat Gul, Farooq Naeem, Muhammad Firaz, et al.

    Background: Tuberculosis (TB) remains a significant public health challenge, particularly in low- and middle-income countries (LMICs) such as Pakistan, where TB and depression frequently co-occur, negatively impacting treatment adherence and outcomes. The cognitive therapy for depression in tuberculosis (CONTROL) trial evaluates the effectiveness of a cognitive behavioral therapy (CBT)-based intervention integrated into TB care. Following the Proctor’s framework, this process evaluation aims to assess key implementation outcomes of the trial, including acceptability, adoption, feasibility, appropriateness, fidelity, penetration, and sustainability, to inform the potential scale-up of the intervention within Pakistan’s routine TB care. Methods: This mixed-methods process evaluation is embedded within the CONTROL randomized controlled trial conducted in Khyber Pakhtunkhwa, Pakistan. Quantitative data collection will include structured implementation outcome measures such as Intervention Appropriateness Measure (IAM), Acceptability of Intervention Measure (AIM), Feasibility of Intervention Measure (FIM), Applied Mental Health Research (AMHR) group tool, Revised Cognitive Therapy Scale (CTS-R), CBT-content delivery assessment checklist, Client Service Receipt Inventory (CSRI), and trial administrative data logs. Qualitative data will comprise semi-structured interviews and focus group discussions. Data collection will be at three points: 8-, 24-, and 32-week post-randomization across 12 TB care facilities. Quantitative data will be analyzed descriptively, while qualitative data will be analyzed thematically, followed by triangulation of findings. Discussion: The process evaluation will inform the implementation of CBT-based intervention within TB care. It will also identify barriers and facilitators for integrating mental health care in the TB control program for future scale-up. Findings will inform policymakers on the feasibility of incorporating mental health interventions into routine TB care, support improved patient outcomes, and contribute to global implementation science on integrated mental health care for chronic diseases. Trial registration: ISRCTN10761003. Registered on November 2023.

  • Open Access

    Coping strategies and resilient behavior among frontline healthcare workers: A scoping review

    by Bilal Ahmad, Khalid Rehman, Shawana Bangash, Rida Zarkaish, Mahdia Babak, Sana Rehman, Samina Ihsan, Farhad Ali Khattak, Muhammad Irfan, Asif Rehman, et al.


  • Open Access

    Barriers to treatment adherence among patients with tuberculosis: a qualitative study of Pakistani nationals and Afghan refugees

    by Noor Sanauddin, Fayaz Ahmad, Maryiam Rahim, Muhammad Awais Paracha, Zohaib Khan, Fatima Khalid Qazi, Shaista Rasool, Mirrat Butt, Farooq Naeem, Muhammad Firaz Khan, et al.

    Objectives Non-adherence to tuberculosis (TB) treatment remains a major challenge in high-burden regions. However, few studies have qualitatively examined the sociocultural and emotional barriers to adherence, particularly among Afghan refugees in Pakistan. This study explores the patient-related, sociocultural and treatment-related barriers to treatment adherence among patients with TB of Pakistani and Afghan origin living in Pakistan. Design We conducted an exploratory qualitative study consisting of semistructured focus group discussions (FGDs) and in-depth interviews (IDIs) with purposively selected multisectoral stakeholders. The data were analysed thematically using a combination of inductive and deductive approaches. Settings We employed a qualitative study design in the TB DOTS (Directly Observed Treatment Short course) centres in the Haripur and Peshawar districts of Khyber Pakhtunkhwa province, Pakistan. Participants We conducted IDIs (n=29) and FGDs (n=11) with three categories of participants: TB healthcare providers, patients with TB and their carers. Results We identified several contributors to lower treatment adherence. These included patient-related barriers (eg, lack of awareness about TB and its treatment), sociocultural barriers (eg, stigma, refugee status of Afghan patients, gender roles and reliance on traditional and spiritual healing) and treatment-related barriers (eg, demanding treatment regimen and TB-induced depression). Conclusion Several personal, sociocultural and treatment-related barriers contribute to lower treatment adherence in patients with TB. A significant contributing factor to treatment non-adherence in patients is the high prevalence of anxiety and depression related to TB and its treatment, for which there is no treatment or counselling available at the DOTS level in Pakistan, warranting the need for mental health interventions that could improve adherence and treatment outcomes for both TB and depression. Trial registration number ISRCTN10761003.